COMMUNIQUÉS West-GlobeNewswire

Vanderbilt’s Dr. Neal Patel Joins Heald as Strategic Advisor to Advance Human-Led Diabetes Reversal
08/07/2025
ALPHARETTA, Ga., July 08, 2025 (GLOBE NEWSWIRE) -- Heald , the human-led, tech-enabled platform redefining diabetes care, proudly announces that Dr. Neal Patel , Chief Informatics Officer at Vanderbilt University [...]
Corza Medical annonce le lancement de la gamme élargie de sutures ophtalmiques Onatec
08/07/2025
PARSIPPANY, New Jersey, 08 juill. 2025 (GLOBE NEWSWIRE) -- Corza Medical, l’une des plus grandes sociétés mondiales du secteur des technologies médicales, annonce ce jour le lancement de sa gamme élargie de sutures [...]
Capsa Healthcare Unveils Industry’s First Consolidated Services Pharmacy Platform
08/07/2025
CANAL WINCHESTER, Ohio, July 08, 2025 (GLOBE NEWSWIRE) -- Capsa Healthcare, a leader in healthcare automation and medication management, today announced the launch of its Consolidated Services Pharmacy Platform (CSPP [...]
Dr. Anosh Ahmed Expands Global Healthcare Leadership Through New Community Health Initiative
08/07/2025
Chicago-based physician announces expansion of charitable programs focused on healthcare access and community wellness Image of Dr. Anosh Ahmed CHICAGO, July 08, 2025 (GLOBE NEWSWIRE) -- Dr. Anosh Ahmed, a physician, [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2025
08/07/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S1 2025
08/07/2025
Communiqué de presse BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S1 2025 Dijon, France 08 juillet 2025 (17h30 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), la société pharmaceutique de spécialités qui développe [...]
CARBIOS : Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF
08/07/2025
COMMUNIQUÉ DE PRESSE INFORMATION REGLEMENTEE : PERMANENTE Titre concerné : Carbios (code ISIN FR0011648716) Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 08 juillet 2025 (18h00 CEST). CARBIOS, ( [...]
Report on Carbios’ liquidity contract with Natixis ODDO BHF
08/07/2025
PRESS RELEASE REGULATED INFORMATION: ONGOING Shares concerned: Carbios (ISIN code: FR0011648716) Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 08 July 2025 (18:00 CEST). CARBIOS , (Euronext Growth [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 27 - 2025
08/07/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 30 juin au 04 juillet 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 27- 2025
08/07/2025
Aggregated presentation by day and by market Statement of transactions in own shares from June 30th to July 4th 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
From Stem Cells to CAR-T: LivMedCell Expands Its Role in the Future of Medicine
08/07/2025
Photo: LivMedCell via FL Communications ISTANBUL, July 08, 2025 (GLOBE NEWSWIRE) -- LivMedCell has officially launched a groundbreaking research collaboration with the University of Pennsylvania’s Perelman School of [...]
ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds
08/07/2025
WESTON, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with [...]
Diagonal Therapeutics Appoints John Lee, M.D., Ph.D., as Chief Medical Officer
08/07/2025
Biotech veteran will lead clinical development of Diagonal’s clustering antibody pipeline, including DIAG723 for hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH) WATERTOWN, Mass., [...]
Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia
08/07/2025
Nonclinical findings provide evidence of the mechanism of action of nomlabofusp and support the potential use of skin FXN concentrations as a novel surrogate endpoint for Larimar’s planned BLA submission in Q2 2026 [...]
Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)
08/07/2025
– Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD – – Broadens global development program for verekitug into third [...]
Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis
08/07/2025
Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a open-label study to a Phase 2b placebo-controlled study. This is a critical step required prior to proceeding to [...]
Jade Biosciences to Participate in Two Upcoming Investor Conferences
08/07/2025
SAN FRANCISCO and VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune [...]
Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer
08/07/2025
Seasoned Leader Brings Deep Experience in Oncology Drug Development as Company Advances Portfolio of Next Generation Therapeutics for Solid Tumors WALTHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, [...]
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
08/07/2025
Substantial clinical need expected to facilitate rapid overall trial enrollment HOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company [...]

Pages